What law school ought to be.

FACULTY HOME
VISITING FACULTY
ADJUNCT FACULTY
OFFICE HOURS
CLASS PAGES
EMERITUS FACULTY
FACULTY PUBLICATIONS
FACULTY EXPERTS
FACULTY IN THE NEWS
VISITING ASSISTANT PROFESSORSHIP PROGRAM

 

California Western, Robert A. Bohrer
Robert A. BohrerRobert A. Bohrer

Professor of Law

LL.M. Harvard University
J.D. University of Illinois
B.A. Haverford College
 [psychology]

Courses Taught: Biotechnology Seminar,
Food and Drug Law, Torts II

Professor Bohrer practiced with the Chicago law firm of Bell, Boyd & Lloyd before returning to academia. Although he has written about such varied topics as the constitutionality of I.Q. testing in the public schools, congressional control of affirmative action, and the risks of toxic substances, since 1984 he has focused primarily on the legal issues raised by developments in biotechnology and pharmaceutical policy.

Bohrer is executive editor of Biotechnology Law Report. He previously served as director of Biotechnology Programs at the University of California at San Diego's Center for Molecular Genetics and and on the board of directors of the La Jolla Institute for Molecular Medicine. Bohrer was the only law professor to serve on the board of directors of the Biotechnology Institute of the U.S. Patent and Trademark Office. While in law school at Illinois, he was a member of Law Review and a teaching assistant in the College of Commerce.

Selected Publications

  • A GUIDE TO BIOTECHNOLOGY LAW AND BUSINESS (2005).
  • "It's the Antigen Stupid: A Risk/Reward Approach to the Problem of Orphan Drug Act Exclusivity for Monoclonal Antibody Therapeutics," 5 Columbia Science & Technology Law Review 1 (2003).
  • "Eschazabal, Genetic Testing and Rawls: The Ethics of Protecting Workers Against Risks," in Biotechnology Law 2002: Biotechnology Patents & Business Strategies (Berholtz & Ludwig, eds., 2002).
  • "A Rawlsian Approach to Solving the Problem of Genetic Discrimination in Toxic Workplaces," 39 San Diego Law Review 747 (2002).
  • "The Trouble With Formularies: Where's the Data When You Need It?" Proceedings of the Fifth Annual Managed Care Law Summit (2002).
  • "Letter: The Pharmaceutical Industry - to Whom is it Accountable?" 343 New England Journal of Medicine 1415 (2000).

Scholarly Presentations

  • "Ethical Issues: Longevity Research and Clinical Trials," Biotechnology Law 2005, Practicing Law Institute California Center, November 2005, San Francisco, CA.
  • "Recent Developments in Patent Law: What do they Mean for University Researchers?" Summer Neuropeptide Society Meeting, July 2005, Miami Beach, CA.
  • "Applying Ethical Reasoning in the Debate Over Social Policy: Embryonic Stem Cell Research," Lawyers' Club, March 2005, San Diego, CA.

Links

Webpage

       Torts II - Summer 2010

 


 

 

 

rbohrer@cwsl.edu     
619-525-1435
225 Cedar Street
San Diego, CA 92101

Publications

Presentations

Links